Treatment of Alopecia Areata With Tofacitinib

Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition

Luzhou Xing, Zhenpeng Dai, Ali Jabbari et al. · Nature Medicine · 2014 · 916 citations · Full text

Cytotoxic T Lymphocytes, Autoimmune Disease, Scleroderma +13

Alopecia areata investigational assessment guidelines–Part II

Elise A. Olsen, Maria K. Hordinsky, Vera H. Price et al. · Journal of the American Academy of Dermatology · 2004 · 764 citations

Ophthalmology, Diagnosis, Clinical Dermatology +3

Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata

Milène K. Crispin, Justin Ko, Brittany G. Craiglow et al. · JCI Insight · 2016 · 336 citations · Full text

Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata

Julian Mackay‐Wiggan, Ali Jabbari, Nhan Nguyen et al. · JCI Insight · 2016 · 281 citations · Full text